An anti-inflammation injectable drug can reduce mucus buildup and improve breathing among asthma patients, a new clinical trial says.
The drug dupilumab (Dupixent) effectively clears up airways plugged by mucus during an asthma attack, researchers reported Monday in the American Journal of Respiratory and Critical Care Medicine.
Results found half as many patients had mucus-plugged airways following treatment with the drug.
"In moderate-to-severe asthma, a buildup of mucus in the lungs can obstruct breathing airways to the point where affected patients suffer limited breathing, severe asthma attacks, and even death," lead researcher Dr. Celeste Porsbjerg said in a news release. She's a professor of severe asthma at Bispebjerg Hospital in Copenhagen, Denmark.
Related
